Bionano Genomics (NASDAQ:BNGO) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Bionano Genomics missed estimated earnings by 22.22%, reporting an EPS of $-0.11 versus an estimate of $-0.09.
Revenue was up $2.81 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.04 which was followed by a 7.14% drop in the share price the next day.
Here's a look at Bionano Genomics's past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.07 | -0.06 | -0.06 | -0.04 |
| EPS Actual | -0.11 | -0.08 | -0.07 | -0.06 |
| Revenue Estimate | 5.68M | 5.57M | 4.23M | 3.52M |
| Revenue Actual | 5.70M | 6.30M | 4.66M | 3.86M |
To track all earnings releases for Bionano Genomics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
